Back
Rocket Pharmaceuticals Stock Price Chart
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Sell
28
RCKT
Rocket Pharmaceuticals
Last Price:
$6.06
Seasonality Move:
9.99%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight selling pressure.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.06 | Sell |
| 20-day SMA: | 7.07 | Sell |
| 50-day SMA: | 7.27 | Sell |
| 200-day SMA: | 13.49 | Sell |
| 8-day EMA: | 6.97 | Sell |
| 20-day EMA: | 7 | Sell |
| 50-day EMA: | 7.6 | Sell |
| 200-day EMA: | 12.56 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 45.13 | Sell |
| Chaikin Money Flow: | -621925 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.84 - 7.58) | Sell |
| Bollinger Bands (100): | (6.99 - 11.25) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 6.62 while RCKT 8-day simple moving average is 7.06, which is a Sell signal.
-
The stock price of RCKT is 6.62 while Rocket Pharmaceuticals 20-day SMA is 7.07, which makes it a Sell.
-
Rocket Pharmaceuticals 50-day simple moving average is 7.27 while RCKT share price is 6.62, making it a Sell technically.
-
RCKT stock price is 6.62 and Rocket Pharmaceuticals 200-day simple moving average is 13.49, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
28
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a SellThe current Rocket Pharmaceuticals [RCKT] share price is $6.62. The Score for RCKT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
712.7M
Price in USD:
6.62
Share Volume:
4.3M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
26.98
52-Week Low:
4.55
Sell
28
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?The Rocket Pharmaceuticals stock price is 6.62 USD today.
-
Will RCKT stock go up or go down?Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rocket Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 6.62 while RCKT 8-day exponential moving average is 6.97, which is a Sell signal.
-
The stock price of RCKT is 6.62 while Rocket Pharmaceuticals 20-day EMA is 7.00, which makes it a Sell.
-
Rocket Pharmaceuticals 50-day exponential moving average is 7.60 while RCKT share price is 6.62, making it a Sell technically.
-
RCKT stock price is 6.62 and Rocket Pharmaceuticals 200-day simple moving average is 12.56, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.24 per share, an increase this year of $0.60 per share, and an increase next year of $0.61 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
-
RCKT Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Rocket Pharmaceuticals is a Sell
-
Rocket Pharmaceuticals Relative Strength Index (RSI) is 45.13, which suggest Rocket Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rocket Pharmaceuticals is (5.84 - 7.58), which suggest Rocket Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Rocket Pharmaceuticals is (6.99 - 11.25), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.